Geopolitics Alpha

FDA has finalized its guidance on apps related to drugs

Published . Updated .

FDA has finalized its guidance on apps related to drugs

In this edition of STAT Health Tech: FDA's guidance on prescription drug use-related software, and telehealth pushing GLP-1s for addiction.

Directly affected

  • No company is named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    A fund of health-care companies

  • XBI SPDR S&P Biotech

    A fund of biotechnology companies

  • UNH UnitedHealth+8.7%

    A large health insurer

  • JNJ Johnson & Johnson-3.3%

    A large health-care company

  • LLY Eli Lilly+11.7%

    A large drug maker

  • PFE Pfizer+7.7%

    A large drug maker

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
XLV———————
XBI———————
UNH———————
JNJ———————
LLY———————
PFE———————

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

FDA has finalized its guidance on apps related to drugs STAT

Source: STAT

Trades by members of Congress and officials in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

How solid “FDA has finalized its guidance on apps related to drugs” looks

12 out of 100

“FDA has finalized its guidance on apps related to drugs” scores 12 out of 100. The score uses 1 sources.